BRSCW Applicant: Diamandis - Mt Sinai (2006)
283
KLKs 5,6,7,8,10,11
Case/control
Proteomics
Breast and Gynecologic Cancers Research
Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel
Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel
Determine sensitivity and specificity of a panel of kallikreins for early ovarian cancer diagnosis
ELISA assays
An oral presentation by Dan Cramer was given at the 2009 AACR annual meeting
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.





